Abstract: Based on Cox proportional hazards model, young age (hazard ratio (HR)=0.952, P=0.001), sustained virological response to HCV (HR=4.638, P=0.044),
C1766T mutation (HR=5.216, P=0.003) and
A1846T mutation (HR=2.332, P=0.031) correlated with HBV DNA reactivation (>=2000IU/ml) after therapy.